THE EFFECT OF HEMODIALYSIS AND HEMOPERFUSION ON SERUM VALPROIC ACID CONCENTRATION

被引：16

作者：

KANDROTAS, RJ

LOVE, JM

GAL, P

OLES, KS

机构：

[1] MOSES CONE MEMORIAL HOSP,GREENSBORO,SC

[2] GREENSBORO AREA HLTH EDUC CTR,GREENSBORO,SC

[3] UNIV N CAROLINA,SCH PHARM,CHAPEL HILL,NC 27514

[4] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT NEUROL,WINSTON SALEM,NC 27103

[5] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,NW AREA HLTH EDUC CTR,WINSTON SALEM,NC 27103

来源：

关键词：

D O I：

10.1212/WNL.40.9.1456

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1456 / 1458

页数：3

共 9 条

[1] BOLODLE TA, 1980, CLIN PHARMACOL THER, V28, P486
[2] VALPROATE PLASMA-PROTEIN BINDING IN THE UREMIC CONDITION
BREWSTER, D
MUIR, NC
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) : 76 - 82
[3] CLOYD JC, 1986, TXB CLIN APPL THERAP, P269
[4] CARBAMAZEPINE CLEARANCE IN HEMODIALYSIS AND HEMOPERFUSION
KANDROTAS, RJ
OLES, KS
GAL, P
LOVE, JM
[J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (02): : 137 - 140
[5] LEVY RH, 1986, APPLIED PHARMACOKINE, P540
[6] MARBURY TC, 1980, DIALYSIS TRANSPLANT, V9, P961
[7] MORTENSEN PB, 1983, INT J CLIN PHARM TH, V21, P64
[8] PLASMA-PROTEIN BINDING OF PHENYTOIN AND WARFARIN IN PATIENTS UNDERGOING RENAL-TRANSPLANTATION
ODARCEDERLOF, I
[J]. CLINICAL PHARMACOKINETICS, 1977, 2 (02) : 147 - 153
[9] WILDER BJ, 1985, CLIN PHARMACOL THER, V34, P501